Cargando…
Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
BACKGROUND: Myasthenia gravis (MG) and animal model of experimental autoimmune myasthenia gravis (EAMG) is the most common autoimmune disorder of neuromuscular transmission. The disease is caused by the breakdown of the acetylcholine receptor (AChR) which is largely due to complement activation at t...
Autores principales: | Soltys, Jindrich, Wu, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524051/ https://www.ncbi.nlm.nih.gov/pubmed/22642809 http://dx.doi.org/10.1186/1476-9255-9-20 |
Ejemplares similares
-
Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo
por: Hepburn, Natalie J., et al.
Publicado: (2008) -
Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis
Publicado: (1978) -
Role of complement in myasthenia gravis
por: San, Pyae Phyo, et al.
Publicado: (2023) -
Structures of the rat complement regulator CrrY
por: Roversi, Pietro, et al.
Publicado: (2011) -
Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats
por: Kato, Chie, et al.
Publicado: (2013)